Inhalation Sciences Sweden AB Logo

Inhalation Sciences Sweden AB

Inhalation research instruments and CRO services for preclinical pharma/biotech development.

ISAB | SPGR

Overview

Corporate Details

ISIN(s):
SE0009983893 (+2 more)
LEI:
54930018BAFIJ0IXTL75
Country:
Sweden
Address:
C/O Kliniskt Forskningscentrum KFC, 141 57 Huddinge
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Inhalation Sciences Sweden AB is a life sciences company specializing in inhalation research. The company develops and sells patented laboratory instruments and provides contract research organization (CRO) services. Its flagship technology, the PreciseInhale® platform, offers precise aerosol generation and exposure control, enabling detailed studies on how inhaled particles affect the respiratory system. This system provides high-quality data on dose-response relationships and regional lung deposition. Through its Inhalation Research Services, the company supports pharmaceutical and biotech clients in the preclinical development of orally inhaled and intra-nasal drug products.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Inhalation Sciences Sweden AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Inhalation Sciences Sweden AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Sweden MBOLIC
Milton Essex Spolka Akcyjna Logo
Develops AI-powered, non-invasive systems for allergy diagnostics & personalized medicine.
Poland MTN
Molecular Partners AG Logo
Pioneering DARPin protein drugs for complex diseases in oncology and virology.
Switzerland MOLN
MorphoSys AG Logo
Biopharma company creating antibody therapies for oncology, with a focus on blood cancers.
Germany MOR
Mycodern Spolka Akcyjna Logo Poland MCD
N4 PHARMA PLC Logo
Developing a nanoparticle delivery system for advanced gene and vaccine therapies.
United Kingdom N4P
NextGen Biomed Ltd. Logo
R&D of biotech medical devices for diabetes care and topical skin treatments.
Israel NXGN
Nicox S.A. Logo
Developing innovative ophthalmology drugs for glaucoma and ocular hypertension.
France COX
ONCIMMUNE HOLDINGS PLC Logo
Antibody biomarker discovery platform for pharma and biotech partners in oncology and autoimmune disease.
United Kingdom ONC
OncoZenge AB Logo
Developing a non-opioid lozenge for oral pain relief in cancer patients.
Sweden ONCOZ

Talk to a Data Expert

Have a question? We'll get back to you promptly.